Key result
Novel TAZ splice site variant linked to Barth syndrome via aberrant exon 3 excision.
Case Report (n=1)
No
This case report identifies a novel pathogenic splice-site variant (c.239-1_239delinsTT) in the TAZ gene that causes exon 3 skipping and leads to Barth syndrome.
Answers are grounded in this paper and cite their sources.
May refine targeted TAZ testing in suspected Barth syndrome; leaves open broader adoption pending replication in additional cases.
). A 3 years old boy with dilated cardiomyopathy, neutropenia and growth retardation was investigated. Genetic screening found a new variant in the junction of intron 2 and exon 3 of the TAZ gene - c.239-1_239delinsTT. Functional analysis of the variant revealed the aberrant splicing of exon 3 leading to its complete excision from mature mRNA and frameshift at the beginning of tafazzin. Variant c.239-1_239delinsTT can be classified as pathogenic based on splicing alteration and typical clinical phenotype observed in TAZ mutation carriers.
No takes yet. Share an insight, caveat, or question.
Sivitskaya et al. (2021) conducted a case report in Barth syndrome (n=1). TAZ gene mutation c.239-1_239delinsTT vs. Healthy family members was evaluated on Identification and functional analysis of TAZ gene mutation. A novel splice site variant c.239-1_239delinsTT in the TAZ gene was identified as the cause of Barth syndrome, leading to aberrant splicing and complete excision of exon 3.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: